Further, a recent meta-analysis that included 7901 IBD patients treated with anti-TNFs did not find an increased risk of anti-TNF exposure compared with non-biologic exposure (RR 1.20, 95% CI: 0.60–2.40) [83]. Here, TNF is linked to inflammatory bowel disease.